Detalhe da pesquisa
1.
Successful use of nirmatrelvir/ritonavir in immunocompromised patients with persistent and/or relapsing COVID-19.
J Antimicrob Chemother
; 78(2): 555-558, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36544352
2.
Loss of speech and functional impairment in Alzheimer's disease-related primary progressive aphasia: predictive factors of decline.
Neurobiol Aging
; 117: 59-70, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35665686